Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,026.30
-14.60 (-1.40%)
At close: Feb 12, 2026
Bharat Parenterals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | -126.26 | 145.17 | 157.15 | 213.04 | 203.89 |
Depreciation & Amortization | 353.22 | 90.21 | 58.82 | 66.61 | 60.29 |
Loss (Gain) From Sale of Assets | 9.76 | 0.85 | 0.91 | 7.4 | 46.91 |
Loss (Gain) From Sale of Investments | 2.83 | - | -3.42 | -11.25 | -5.13 |
Stock-Based Compensation | - | 1.4 | 5.31 | -4.01 | - |
Provision & Write-off of Bad Debts | 7.89 | - | - | - | - |
Other Operating Activities | -288.04 | -31.76 | 10 | 2.06 | 1.47 |
Change in Accounts Receivable | -251.55 | -279.94 | -391.58 | -51.01 | 114.62 |
Change in Inventory | -104.84 | -236.26 | -170.82 | 16.72 | 63.83 |
Change in Accounts Payable | 146.87 | 86.28 | 346.39 | -36.22 | -164.38 |
Change in Other Net Operating Assets | -22.41 | 136.97 | 197.04 | -424.09 | -77.76 |
Operating Cash Flow | -272.54 | -47.06 | 216.64 | -220.75 | 244.48 |
Operating Cash Flow Growth | - | - | - | - | 69.13% |
Capital Expenditures | -290.76 | -1,043 | -916.01 | -47.63 | -8.4 |
Sale of Property, Plant & Equipment | 4.55 | 7.01 | 15.09 | 0.8 | 0.62 |
Cash Acquisitions | -543.88 | - | - | - | - |
Investment in Securities | -52.67 | - | 118.24 | 266.42 | -422.74 |
Other Investing Activities | -491.09 | -11.83 | 4.48 | -2 | -3.2 |
Investing Cash Flow | -1,374 | -1,048 | -778.19 | 217.59 | -433.72 |
Short-Term Debt Issued | 199.14 | 455.94 | 332.43 | 15.86 | 11.93 |
Long-Term Debt Issued | 27.05 | 622.42 | - | 36.5 | 112 |
Total Debt Issued | 226.19 | 1,078 | 332.43 | 52.36 | 123.93 |
Long-Term Debt Repaid | - | - | -12.44 | -24.71 | -14.53 |
Total Debt Repaid | - | - | -12.44 | -24.71 | -14.53 |
Net Debt Issued (Repaid) | 226.19 | 1,078 | 319.99 | 27.65 | 109.41 |
Issuance of Common Stock | 1,473 | 4.46 | - | 4.46 | - |
Common Dividends Paid | -5.82 | -4.33 | - | - | - |
Other Financing Activities | -129.5 | 25.8 | 285.99 | -9.67 | -4.42 |
Financing Cash Flow | 1,564 | 1,104 | 605.98 | 22.43 | 104.98 |
Miscellaneous Cash Flow Adjustments | 0 | -0 | 0 | - | -0 |
Net Cash Flow | -82.67 | 9.38 | 44.42 | 19.27 | -84.26 |
Free Cash Flow | -563.3 | -1,090 | -699.37 | -268.38 | 236.07 |
Free Cash Flow Margin | -16.55% | -41.73% | -31.89% | -12.64% | 11.39% |
Free Cash Flow Per Share | -85.95 | -187.24 | -121.11 | -46.75 | 41.20 |
Cash Interest Paid | 129.5 | 32.25 | 21.86 | 9.67 | 3.94 |
Cash Income Tax Paid | 105.95 | 94.63 | 87.92 | 56.7 | 66.77 |
Levered Free Cash Flow | -1,096 | -987 | -959.81 | 83.02 | 114.38 |
Unlevered Free Cash Flow | -1,021 | -967.12 | -946.15 | 89.07 | 116.84 |
Change in Working Capital | -231.94 | -292.94 | -18.97 | -494.6 | -63.69 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.